Hokkaido University Collection of Scholarly and Academic Papers >
Hokkaido University Hospital >
Peer-reviewed Journal Articles, etc >
Association between the use of antibiotics and efficacy of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer
This item is licensed under:Creative Commons Attribution-NonCommercial 4.0 International
Title: | Association between the use of antibiotics and efficacy of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer |
Authors: | Nakano, Shintaro Browse this author | Komatsu, Yoshito Browse this author →KAKEN DB | Kawamoto, Yasuyuki Browse this author →KAKEN DB | Saito, Rika Browse this author | Ito, Ken Browse this author | Nakatsumi, Hiroshi Browse this author →KAKEN DB | Yuki, Satoshi Browse this author | Sakamoto, Naoya Browse this author →KAKEN DB |
Keywords: | antibiotics | gemcitabine plus nab-paclitaxel | pancreatic cancer | progression-free survival | retrospective cohort |
Issue Date: | 25-Sep-2020 |
Publisher: | Lippincott Williams & Wilkins (LWW) |
Journal Title: | Medicine |
Volume: | 99 |
Issue: | 39 |
Start Page: | e22250 |
Publisher DOI: | 10.1097/MD.0000000000022250 |
Abstract: | It is unclear whether the use of antibiotics is related to the efficacy of gemcitabine plus nab-paclitaxel (GnP). Therefore, we investigated the association between the use of antibiotics and efficacy of GnP. We conducted a retrospective single center study from January 2014 to December 2018 in Hokkaido University Hospital. Ninety-nine patients were eligible for the study. Thirty-seven used antibiotics (U) and 62 did not use antibiotics (NU) during GnP therapy. In the U group, 15 patients used beta-lactam antibiotics, 21 used new quinolones, and 1 used carbapenem. The median progression-free survival was 5.8 and 2.7 months (hazards ratio [HR] .602, 95% confidence interval [CI] .391-.928,P = .022) and the median overall survival was 11.0 and 8.4 months (HR .768, 95% CI .491-1.202,P = .248) in the U and not use antibiotics groups, respectively. Antibiotic use (HR .489, 95% CI .287-.832,P = .008) and locally advanced pancreatic cancer (HR 1.808, 95% CI 1.051-3.112,P = .032) were independent prognostic factors for progression-free survival. Antibiotic use was associated with a higher efficacy of GnP, and therefore, it may be employed as a novel treatment strategy. |
Rights: | http://creativecommons.org/licenses/by-nc/4.0 |
Type: | article |
URI: | http://hdl.handle.net/2115/79870 |
Appears in Collections: | 北海道大学病院 (Hokkaido University Hospital) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
|